Back to funds

Birchview Capital, LP

hedge fundUpdated 9 days ago

Managed by Birchview Capital, Lp • Latest filing Q3 2026

Portfolio value
$173.1M
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$170.8M
Q1 2026$175.7M
Q2 2026$213.8M
Q3 2026$173.1M

Top holdings

79 positions as of Q3 2026

View filing
K

KLA CORPORATION

Value
$32.5M
Shares
166.9K
% Port
18.80%
C

BRISTOL-MYERS SQUIBB CO

Value
$14M
Shares
224.2K
% Port
8.08%
L

LAM RESEARCH CORPORATION

Value
$9.9M
Shares
30.0K
% Port
5.69%
B

BIODESIX INC

Value
$8.6M
Shares
286.8K
% Port
4.94%
C

CORCEPT THERAPEUTICS INC

Value
$6.4M
Shares
55.2K
% Port
3.67%
O

OVINTIV INC

Value
$6.2M
Shares
107.5K
% Port
3.59%
R

ULTRAGENYX PHARMACEUTICAL INC

Value
$5.6M
Shares
373.7K
% Port
3.24%
S

SOLID BIOSCIENCES INC

Value
$5.2M
Shares
716.0K
% Port
2.99%
P

PROTAGONIST THERAPEUTICS INC

Value
$4.9M
Shares
35.0K
% Port
2.85%
P

PROTHENA CORP PLC

Value
$3.8M
Shares
449.0K
% Port
2.17%
H

HALOZYME THERAPEUTICS INC

Value
$3.7M
Shares
33.4K
% Port
2.13%
S

STOKE THERAPEUTICS INC

Value
$3.6M
Shares
138.0K
% Port
2.07%
N

NEUROCRINE BIOSCIENCES INC

Value
$3.6M
Shares
25.2K
% Port
2.06%
A

ACADIA PHARMACEUTICALS INC

Value
$3.4M
Shares
171.0K
% Port
1.99%
N

INTELLIA THERAPEUTICS INC

Value
$3.4M
Shares
281.4K
% Port
1.96%
N

NEKTAR THERAPEUTICS

Value
$2.8M
Shares
46.0K
% Port
1.61%
V

VIR BIOTECHNOLOGY INC

Value
$2.5M
Shares
227.0K
% Port
1.47%
Z

ZENAS BIOPHARMA INC

Value
$2.5M
Shares
93.4K
% Port
1.45%
?
19.N/A

CONTINEUM THERAPEUTICS INC (CTNM) P @ 15.0 01/15/2027

Value
$2.3M
Shares
3.5K
% Port
1.31%
A

ABIVAX SA

Value
$2.1M
Shares
21.0K
% Port
1.20%

Explore